BERRUTI, Alfredo
 Distribuzione geografica
Continente #
NA - Nord America 4.237
EU - Europa 2.117
AS - Asia 1.690
SA - Sud America 183
AF - Africa 116
OC - Oceania 108
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.453
Nazione #
US - Stati Uniti d'America 4.006
IT - Italia 625
IN - India 362
DE - Germania 331
CN - Cina 327
GB - Regno Unito 200
FR - Francia 150
CA - Canada 149
IL - Israele 128
VN - Vietnam 121
ES - Italia 107
JP - Giappone 105
AU - Australia 97
TR - Turchia 91
PL - Polonia 88
KR - Corea 87
BR - Brasile 65
PH - Filippine 65
MX - Messico 57
NL - Olanda 57
RO - Romania 57
RU - Federazione Russa 52
PK - Pakistan 45
IE - Irlanda 44
CZ - Repubblica Ceca 40
GR - Grecia 40
HK - Hong Kong 36
CL - Cile 35
SA - Arabia Saudita 35
TH - Thailandia 35
AR - Argentina 34
EG - Egitto 32
MY - Malesia 31
BE - Belgio 30
CH - Svizzera 30
ID - Indonesia 30
PT - Portogallo 30
ZA - Sudafrica 29
IQ - Iraq 28
UA - Ucraina 28
AT - Austria 24
FI - Finlandia 24
IR - Iran 23
JO - Giordania 23
TW - Taiwan 23
SE - Svezia 22
DZ - Algeria 21
HR - Croazia 19
BG - Bulgaria 18
CO - Colombia 18
HU - Ungheria 16
LB - Libano 15
SG - Singapore 15
DK - Danimarca 14
EC - Ecuador 14
LT - Lituania 12
NZ - Nuova Zelanda 11
NO - Norvegia 10
RS - Serbia 10
KE - Kenya 9
SK - Slovacchia (Repubblica Slovacca) 9
KW - Kuwait 8
NP - Nepal 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
LK - Sri Lanka 7
AL - Albania 6
BD - Bangladesh 6
MA - Marocco 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
ET - Etiopia 5
LV - Lettonia 5
BO - Bolivia 4
MK - Macedonia 4
MN - Mongolia 4
PA - Panama 4
JM - Giamaica 3
MT - Malta 3
NG - Nigeria 3
NI - Nicaragua 3
PR - Porto Rico 3
SI - Slovenia 3
SV - El Salvador 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
LY - Libia 2
MM - Myanmar 2
VE - Venezuela 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
Totale 8.438
Città #
Fairfield 361
Houston 319
Woodbridge 250
Seattle 196
Ashburn 192
Santa Cruz 187
Ann Arbor 184
Buffalo 168
Wilmington 131
Cambridge 121
Torino 121
Jerusalem 113
Beijing 79
Dong Ket 77
Warsaw 57
Shanghai 50
Pisa 47
Bengaluru 46
University Park 44
San Diego 37
Chicago 36
Brescia 35
Wuhan 32
Milan 31
New York 31
Dublin 30
Hangzhou 30
Mumbai 29
Mountain View 28
Tokyo 27
Las Vegas 26
London 26
Toronto 24
Ankara 23
Hyderabad 23
Los Angeles 23
Clearwater 22
Rome 22
Sydney 21
Cairo 20
Delhi 20
Guangzhou 20
Muizenberg 20
Nanjing 20
Athens 19
Dallas 19
Ottawa 19
Phoenix 19
Chengdu 18
Santiago 18
Baltimore 17
Hanoi 17
Istanbul 17
Gurgaon 16
Jakarta 16
Vienna 16
Bangalore 15
Bethesda 15
Nürnberg 15
Seoul 15
Turin 15
Central 14
Cleveland 14
Kolkata 14
Paris 14
Philadelphia 14
Ahmedabad 13
Bangkok 13
Barcelona 13
Beirut 13
Helsinki 13
Ho Chi Minh City 13
Madrid 13
Pittsburgh 13
Redmond 13
Taipei 13
Amsterdam 12
Bologna 12
Easton 12
Prague 12
Atlanta 11
Austin 11
Buenos Aires 11
Jeddah 11
Lake Forest 11
Melbourne 11
Riva 11
Vancouver 11
Boardman 10
Chennai 10
Duncan 10
Henderson 10
Iasi 10
Jodhpur 10
Moscow 10
San Francisco 10
Amman 9
Florence 9
Mexico City 9
Munich 9
Totale 4.137
Nome #
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification., file e27ce426-bf6b-2581-e053-d805fe0acbaa 2.529
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease, file e27ce426-bc07-2581-e053-d805fe0acbaa 482
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior., file e27ce426-c97f-2581-e053-d805fe0acbaa 472
Management of adjuvant mitotane therapy following resection of adrenal cancer., file e27ce429-8e03-2581-e053-d805fe0acbaa 446
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy., file e27ce42a-16fa-2581-e053-d805fe0acbaa 393
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients, file e27ce426-bb3d-2581-e053-d805fe0acbaa 380
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain, file e27ce428-c321-2581-e053-d805fe0acbaa 364
Enzalutamide in prostate cancer after chemotherapy., file e27ce426-e518-2581-e053-d805fe0acbaa 357
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study., file e27ce429-f70f-2581-e053-d805fe0acbaa 259
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome, file e27ce428-c2d0-2581-e053-d805fe0acbaa 247
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer., file e27ce426-c97c-2581-e053-d805fe0acbaa 243
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis, file e27ce426-9e3b-2581-e053-d805fe0acbaa 211
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013), file e27ce427-3a74-2581-e053-d805fe0acbaa 192
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study., file e27ce426-f285-2581-e053-d805fe0acbaa 181
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen, file e27ce426-c9de-2581-e053-d805fe0acbaa 161
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†, file e27ce431-1db6-2581-e053-d805fe0acbaa 148
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment, file e27ce428-ca03-2581-e053-d805fe0acbaa 144
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer, file e27ce42b-baf6-2581-e053-d805fe0acbaa 130
Restless Legs Syndrome as a Cause of Sleep Disturbances in Cancer Patients Receiving Chemotherapy, file e27ce42a-55d3-2581-e053-d805fe0acbaa 129
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases., file e27ce426-da20-2581-e053-d805fe0acbaa 126
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer, file e27ce42d-7ddc-2581-e053-d805fe0acbaa 124
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma, file e27ce431-2947-2581-e053-d805fe0acbaa 112
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients, file e27ce42d-4ee3-2581-e053-d805fe0acbaa 96
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients., file e27ce426-da21-2581-e053-d805fe0acbaa 86
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study, file e27ce42d-1bea-2581-e053-d805fe0acbaa 81
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer, file e27ce426-b231-2581-e053-d805fe0acbaa 80
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy, file e27ce431-0e44-2581-e053-d805fe0acbaa 77
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆, file e27ce42f-4f65-2581-e053-d805fe0acbaa 70
Cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells, file e27ce42f-b58a-2581-e053-d805fe0acbaa 70
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2, file e27ce431-2f96-2581-e053-d805fe0acbaa 57
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer, file e27ce431-42ac-2581-e053-d805fe0acbaa 57
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy, file e27ce435-523e-2581-e053-d805fe0acbaa 45
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question, file e27ce432-246d-2581-e053-d805fe0acbaa 39
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study, file e27ce434-5d78-2581-e053-d805fe0acbaa 34
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma, file e27ce431-3fb6-2581-e053-d805fe0acbaa 26
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study, file e27ce435-8715-2581-e053-d805fe0acbaa 26
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma, file e27ce431-3fb7-2581-e053-d805fe0acbaa 23
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence., file e27ce433-fabc-2581-e053-d805fe0acbaa 22
Quality of Life, Anxiety and Depression in Soft Tissue Sarcomas as Compared to More Common Tumours: An Observational Study, file e27ce429-a452-2581-e053-d805fe0acbaa 18
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence., file e27ce42e-ce06-2581-e053-d805fe0acbaa 11
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy, file e27ce434-5e3b-2581-e053-d805fe0acbaa 9
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study, file e27ce434-923e-2581-e053-d805fe0acbaa 9
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain, file e27ce428-c7da-2581-e053-d805fe0acbaa 8
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021, file b1b50217-716c-471e-93fe-613f31d1b525 7
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma, file e27ce42b-ee75-2581-e053-d805fe0acbaa 6
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma, file 8571e642-94fe-46dd-b28b-886f2bba4ad2 5
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy, file e27ce426-cc03-2581-e053-d805fe0acbaa 4
Pitfalls in the diagnosis of adrenocortical tumors: A lesson from 300 consultation cases, file e27ce427-f9fc-2581-e053-d805fe0acbaa 4
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas, file e27ce42d-ec68-2581-e053-d805fe0acbaa 4
Quality of Life, Anxiety and Depression in Soft Tissue Sarcomas as Compared to More Common Tumours: An Observational Study, file e27ce429-a31f-2581-e053-d805fe0acbaa 3
Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?, file e27ce426-c583-2581-e053-d805fe0acbaa 2
Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas, file e27ce427-2caa-2581-e053-d805fe0acbaa 2
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy., file e27ce42a-16fb-2581-e053-d805fe0acbaa 2
Restless Legs Syndrome as a Cause of Sleep Disturbances in Cancer Patients Receiving Chemotherapy, file e27ce42a-5782-2581-e053-d805fe0acbaa 2
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features., file e27ce42a-98ea-2581-e053-d805fe0acbaa 2
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone., file e27ce42d-4de3-2581-e053-d805fe0acbaa 2
Development and validation of a patient-physician relationship index in the advanced cancer setting, file e27ce426-abad-2581-e053-d805fe0acbaa 1
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer., file e27ce426-c97d-2581-e053-d805fe0acbaa 1
Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis, file e27ce426-ca49-2581-e053-d805fe0acbaa 1
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, cremona, Italy (2010), file e27ce426-dbce-2581-e053-d805fe0acbaa 1
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience, file e27ce42d-8f61-2581-e053-d805fe0acbaa 1
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme, file e27ce42d-d676-2581-e053-d805fe0acbaa 1
Totale 8.825
Categoria #
all - tutte 11.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019489 0 0 0 0 0 0 0 0 0 130 200 159
2019/20201.282 137 99 85 179 135 103 95 102 117 91 81 58
2020/20211.095 45 105 66 50 92 81 126 126 81 96 88 139
2021/20222.323 154 66 97 213 160 172 251 202 224 185 360 239
2022/20232.135 125 196 311 243 202 289 181 128 179 188 88 5
2023/2024132 9 3 16 12 12 14 26 27 10 3 0 0
Totale 8.825